This is a promotional email for UK Healthcare Professionals only, sent on behalf of Sobi.
Click here for Prescribing Information and Adverse Event reporting.
Problems viewing this email? | View it in your browser
|
|
|
|
Time for Change
Webinar Series |
|
|
|
|
| This is a promotional webinar series organised and funded by Sobi for UK healthcare professionals only. This webinar series will be recorded.
|
|
|
| Join us for this interactive webinar series featuring engaging talks on sharing the best practice in immune thrombocytopenia and chronic liver disease-associated thrombocytopenia care
|
Throughout the talks you may submit any questions you have to the faculty.
There will be a Q&A session at the end of each webinar to address these.
|
Webinar 1, Wednesday 29th March 2023
Webinar 2, Thursday 18th May 2023
Webinar 3, Thursday 21st September 2023
19:00 - 20:30 |
|
|
|
|
| Webinar 1: Wednesday 29th March 2023 19:00 - 20:30 |
| TIME |
SESSION |
FACULTY |
| 19:00 - 19:10 |
Chair’s Welcome and Introduction |
Dr Nichola Cooper |
| 19:10 - 19:40 |
Establishing an ITP Service |
Dr Gill Lowe |
| 19:40 - 20:10 |
An Update on the Management of ITP |
Dr Gary Benson |
| 20:10 - 20:30 |
Q&A (Chaired by Dr Nichola Cooper) |
All |
| 20:30 |
Chair’s Summary and Close of Webinar |
Dr Nichola Cooper |
|
|
|
| Webinar 2: Thursday 18th May 2023 19:00 - 20:30 |
| TIME |
SESSION |
FACULTY |
| 19:00 - 19:10 |
Chair’s Welcome and Introduction |
Dr Vickie McDonald |
| 19:10 - 19:40 |
Present Day Management of Primary ITP |
Dr Sue Pavord |
| 19:40 - 20:10 |
Defining ITP Chronic Disease |
Dr Drew Provan |
| 20:10 - 20:30 |
Q&A (Chaired by Dr Vickie McDonald) |
All |
| 20:30 |
Chair’s Summary and Close of Webinar |
Dr Vickie McDonald |
|
|
|
| Webinar 3: Thursday 21st September 2023 19:00 - 20:30 |
| TIME |
SESSION |
FACULTY |
| 19:00 - 19:10 |
Chair’s Welcome and Introduction |
Dr Gill Lowe |
| 19:10 - 19:40 |
An Update on the Management of
Thrombocytopenia in Chronic Liver Disease |
Dr Jecko Thachil |
| 19:40 - 20:10 |
An MDT Approach to Managing Chronic Liver Disease |
Ms Sital Shah |
| 20:10 - 20:30 |
Q&A (Chaired by Dr Gill Lowe) |
All |
| 20:30 |
Chair’s Summary and Close of Webinar |
Dr Gill Lowe |
|
|
|
|
|
Dr Nichola Cooper, Consultant Haematologist, Imperial College NHS Trust;
Dr Gill Lowe, Consultant Haematologist, University Hospitals Birmingham;
Dr Gary Benson, Consultant Haematologist, Belfast City Hospital;
Dr Vickie McDonald, Consultant Haematologist, Barts Health NHS Trust;
Dr Sue Pavord, Consultant Haematologist, Oxford University Hospitals;
Dr Drew Provan, Reader in Autoimmune Haematology, Barts and the London School of Medicine;
Dr Jecko Thatchil, Consultant Haematologist, Manchester University NHS Foundation Trust;
Ms Sital Shah, Lead Pharmacist Hepatology, King’s College Hospital NHS Foundation Trust.
|
|
|
|
|
For further queries, please contact Iceberg Medical (meeting secretariat) at timeforchange@icebergmedical.com or +44 1494 776 289.
Alternatively, please contact Jaspal Dhir (National Account Manager) at Sobi at jaspal.dhir@sobi.com or +44 7967 597 567.
Please read more about how Sobi processes personal data and about your rights in Sobi’s Privacy Policy HERE. |
|
|
 |
Doptelet is indicated for the treatment of severe thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo an invasive procedure.1
Doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins).1
Treatment should be initiated by and remain under the supervision of a physician who is experienced in the treatment of haematological diseases.1
|
|
|
|
Job code: PP-17988
Date of preparation: March 2023 |
 |
|
| ▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (for United Kingdom) and www.hpra.ie (for Republic of Ireland). Adverse events should also be reported to Swedish Orphan Biovitrum Ltd at medical.info.uk@sobi.com or Telephone +44 (0) 800 111 4754 |
|
| Click here for Prescribing Information and Adverse Event Reporting |
This email has been forwarded to you by Data4NHS, on behalf of Sobi.
Manage your Data4NHS profile by submitting your changes HERE.
View our privacy policy HERE.
UNSUBSCRIBE. |
|
|
